Deepak N Amarapurkar

Summary

Publications

  1. ncbi request reprint Extrahepatic manifestations of viral hepatitis
    Deepak N Amarapurkar
    Department of Gastroenterology, BYL Nair Hospital, TN Medical College, Mumbai, India
    Ann Hepatol 1:192-5. 2002
  2. ncbi request reprint Combination of Peginterferon alpha-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B- an Indian experience
    Deepak N Amarapurkar
    Head Gastroenterology Department, Bombay Hospital and Medical Research Center, Mumbai, India
    Ann Hepatol 4:56-9. 2005
  3. ncbi request reprint Antiviral therapy of decompensated cirrhosis due to hepatitis C viral infection
    Deepak N Amarapurkar
    Gastroenterology Department, Bombay Hospital and Medical Research Centre, Mumbai
    Trop Gastroenterol 26:119-22. 2005
  4. ncbi request reprint Primary mesenteric venous thrombosis: a study from western India
    Deepak N Amarapurkar
    Gastroenterology Department, Bombay Hospital and Medical Research Center, Mumbai, India
    Indian J Gastroenterol 26:113-7. 2007
  5. ncbi request reprint Prevalence of non-alcoholic fatty liver disease: population based study
    Deepak Amarapurkar
    Department of Gastroenterology, Jagjivanram Western Railway Hospital, Mumbai
    Ann Hepatol 6:161-3. 2007
  6. pmc Management of coagulopathy in patients with decompensated liver cirrhosis
    Pooja D Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai 400 020, India
    Int J Hepatol 2011:695470. 2011
  7. pmc Prescribing medications in patients with decompensated liver cirrhosis
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, New Prabhadevi Road, Prabhadevi, Mumbai 400 025, India
    Int J Hepatol 2011:519526. 2011
  8. ncbi request reprint Diagnostic laparoscopy in the era of modern imaging--retrospective analysis from a single center
    Deepak Amarapurkar
    Department of Gastroenterology and Hepatology, Bombay Hospital and Medical Research Centre, 12, Marine Lines, Mumbai 400 020, India
    Indian J Gastroenterol 32:302-6. 2013
  9. ncbi request reprint Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis
    Amarapurkar Deepak
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, India
    Trop Gastroenterol 32:279-84. 2011
  10. pmc Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai 400025, India
    World J Gastroenterol 14:741-6. 2008

Collaborators

Detail Information

Publications42

  1. ncbi request reprint Extrahepatic manifestations of viral hepatitis
    Deepak N Amarapurkar
    Department of Gastroenterology, BYL Nair Hospital, TN Medical College, Mumbai, India
    Ann Hepatol 1:192-5. 2002
    ..AIMS AND OBJECTS: To study the prevalence of extrahepatic manifestations of viral hepatitis and follow the course of the disease in response to antiviral therapy whenever indicated...
  2. ncbi request reprint Combination of Peginterferon alpha-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B- an Indian experience
    Deepak N Amarapurkar
    Head Gastroenterology Department, Bombay Hospital and Medical Research Center, Mumbai, India
    Ann Hepatol 4:56-9. 2005
    ....
  3. ncbi request reprint Antiviral therapy of decompensated cirrhosis due to hepatitis C viral infection
    Deepak N Amarapurkar
    Gastroenterology Department, Bombay Hospital and Medical Research Centre, Mumbai
    Trop Gastroenterol 26:119-22. 2005
    ..For decompensated HCV cirrhosis, liver transplantation is the only available treatment. Only a few studies in world literature have used antiviral therapy in this situation...
  4. ncbi request reprint Primary mesenteric venous thrombosis: a study from western India
    Deepak N Amarapurkar
    Gastroenterology Department, Bombay Hospital and Medical Research Center, Mumbai, India
    Indian J Gastroenterol 26:113-7. 2007
    ..The prevalence and clinical spectrum of mesenteric venous thrombosis (MVT) in India is largely unknown...
  5. ncbi request reprint Prevalence of non-alcoholic fatty liver disease: population based study
    Deepak Amarapurkar
    Department of Gastroenterology, Jagjivanram Western Railway Hospital, Mumbai
    Ann Hepatol 6:161-3. 2007
    ..Majority of data comes from hospital based studies including small number of patients. Therefore this study was planned to estimate the prevalence of NAFLD in general population...
  6. pmc Management of coagulopathy in patients with decompensated liver cirrhosis
    Pooja D Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai 400 020, India
    Int J Hepatol 2011:695470. 2011
    ..Patients with liver cirrhosis may also be at increased risk of thrombosis. In this paper, we will discuss coagulopathy, increased risk of thrombosis, and their management in decompensated liver cirrhosis...
  7. pmc Prescribing medications in patients with decompensated liver cirrhosis
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, New Prabhadevi Road, Prabhadevi, Mumbai 400 025, India
    Int J Hepatol 2011:519526. 2011
    ..Monitoring of the liver function at frequent intervals is highly recommended...
  8. ncbi request reprint Diagnostic laparoscopy in the era of modern imaging--retrospective analysis from a single center
    Deepak Amarapurkar
    Department of Gastroenterology and Hepatology, Bombay Hospital and Medical Research Centre, 12, Marine Lines, Mumbai 400 020, India
    Indian J Gastroenterol 32:302-6. 2013
    ..A retrospective analysis of utility and outcomes of diagnostic laparoscopy at our center in the last 5 years was done...
  9. ncbi request reprint Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis
    Amarapurkar Deepak
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, India
    Trop Gastroenterol 32:279-84. 2011
    ..This may be useful in diagnosing overt and latent form of MPD in intra-abdominal venous thrombosis (IAVT), consisting of BCS and PVT...
  10. pmc Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai 400025, India
    World J Gastroenterol 14:741-6. 2008
    ..To define the parameters that positively predict diagnosis of Crohn's disease (CD) and differentiate it from gastrointestinal tuberculosis (GITB)...
  11. ncbi request reprint Genotype III - HCV infection
    D N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, India
    Trop Gastroenterol 28:58-63. 2007
  12. ncbi request reprint Role of liver biopsy in management of chronic hepatitis B and chronic hepatitis C
    Deepak Amarapurkar
    Bombay Hospital and Medical Research Centre, Mumbai
    Trop Gastroenterol 28:67-8. 2007
  13. ncbi request reprint Telbivudine: a new treatment for chronic hepatitis B
    Deepak N Amarapurkar
    Department of Gastroenterology and Hepatology, Bombay Hospital and Medical Research Centre, Mumbai 400025, India
    World J Gastroenterol 13:6150-5. 2007
    ..Telbivudine is one of the most potent antiviral agents for chronic hepatitis B virus and was approved by the FDA in late 2006...
  14. pmc Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, D 401 Ameya Society, New Prabhadevi Road, Mumbai 400025, India
    World J Gastroenterol 14:278-85. 2008
    ..To evaluate patterns of obstruction, etiological spectrum and non-surgical treatment in patients with Budd-Chiari syndrome in India...
  15. ncbi request reprint Do different hepatitis C virus genotypes behave differently?
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai
    Trop Gastroenterol 28:99-104. 2007
    ..The natural history of hepatitis C genotype III infection, the predominant form in India, is not wholly understood. This study attempted to compare the natural history of diseases due to genotypes III and I...
  16. ncbi request reprint Impact of diabetes mellitus on outcome of HCC
    Deepak N Amarapurkar
    Ameya RBI Employees, Co Op Housing Society, Prabhadevi, Mumbai
    Ann Hepatol 7:148-51. 2008
    ..We planned a prospective analysis to identify impact of DM in Indian patients with HCC...
  17. ncbi request reprint A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract
    D N Amarapurkar
    Department of Gastroenterology and Hepatology, Bombay Hospital Medical Research Centre, Mumbai
    Trop Gastroenterol 31:101-4. 2010
    ..However, there has been change in pattern of gastrointestinal neuroendocrine tumors over last few years. There is limited data available on epidemiology and patterns of these tumors in India...
  18. ncbi request reprint Intrinsic factor antibody negative atrophic gastritis; is it different from pernicious anaemia?
    D N Amarapurkar
    Department of Gastroenterology and Hepatology, Bombay Hospital and Medical Research Centre, Mumbai, India
    Trop Gastroenterol 31:266-70. 2010
    ..Parietal cell antibody (PCA) and intrinsic factor antibody (IFA) are characteristic of autoimmune gastritis, of which IFA is more specific. Patients who are IFA negative are considered under the category of chronic atrophic gastritis...
  19. ncbi request reprint How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
    Deepak N Amarapurkar
    Bombay Hospital and Medical Research Center, Mumbai, India
    J Gastroenterol Hepatol 22:788-93. 2007
    ..To date, however, data on the natural history and impact of NAFLD causing serious significant chronic liver disease are lacking and there is a need for prospective, cooperative studies...
  20. ncbi request reprint An experience with covered transjugular intrahepatic portosystemic shunt for refractory ascites from western India
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, India
    Ann Hepatol 5:103-8. 2006
    ..Use of covered TIPS has shown to improve shunt patency rate over uncovered TIPS. This retrospective analysis was performed on patients with RA to assess efficacy of TIPS, both covered and uncovered...
  21. ncbi request reprint Gastrointestinal luminal tuberculosis: establishing the diagnosis
    Nikhil Patel
    Department of Gastroenterology, Jagjivanram Hospital, Mumbai, India
    J Gastroenterol Hepatol 19:1240-6. 2004
    ..To study the profile of gastrointestinal luminal tuberculosis (GITB) patients who have been treated on a confirmed and a presumptive diagnosis...
  22. ncbi request reprint Non-alcoholic steatohepatitis in type 2 diabetes mellitus
    Parijat Gupte
    Gastroenterology Center, Jagjivanram Hospital, Mumbai Central, Mumbai, Maharashtra, India
    J Gastroenterol Hepatol 19:854-8. 2004
    ..Hence we have studied its prevalence and correlation of biochemical parameters with histological grades of non-alcoholic fatty liver disease (NAFLD) in otherwise asymptomatic type 2 DM patients...
  23. ncbi request reprint Monitoring and management of antituberculosis drug induced hepatotoxicity
    Subhash Agal
    Department of Gastroenterology, Jagjivanram Hospital, Mumbai, India
    J Gastroenterol Hepatol 20:1745-52. 2005
    ..This often results in inadequate therapy. The risk of fulminant hepatic failure and mortality is high once icteric hepatitis develops. There is no consensus on monitoring protocols and for the reintroduction of ATT...
  24. doi request reprint Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region
    Deepak Amarapurkar
    Bombay Hospital and Medical Research Centre, Mumbai, India
    J Gastroenterol Hepatol 24:955-61. 2009
    ..In conclusion, HCC surveillance could be effective at reducing disease-specific mortality with acceptable cost-effectiveness among selected patient groups, provided it is a well-organized program...
  25. doi request reprint Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India
    Vinod H Gupta
    Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India
    J Gastroenterol Hepatol 28:1368-74. 2013
    ..The purpose of this study was to assess the association of N-acetyltransferase 2 (NAT2) and cytochrome P450 2E1 (CYP2E1) gene polymorphism with anti-TB DIH in Western Indian population...
  26. ncbi request reprint Monotherapy with peginterferon alpha-2b {12 kDa} for chronic hepatitis C infection in patients undergoing haemodialysis
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, India
    Trop Gastroenterol 28:16-8. 2007
    ..Ribavirin is contraindicated in patients with chronic renal failure (CRF). Conventional Interferon monotherapy is effective in around 30% of such patients. There is scanty data on the use of Peginterferon monotherapy in them...
  27. ncbi request reprint Increased prevalence of type II diabetes mellitus in hepatitis C virus infection in western India
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, India
    Trop Gastroenterol 29:148-52. 2008
    ..Type II diabetes mellitus (DM) has been shown as more common in patients with hepatitis C virus infection (HCV). Similar data from India is not available...
  28. ncbi request reprint Spectrum of autoimmune liver diseases in western India
    Deepak N Amarapurkar
    Gastroenterology Department, Bombay Hospital and Medical Research Center, Mumbai, India
    J Gastroenterol Hepatol 22:2112-7. 2007
    ..The prevalence and spectrum of autoimmune liver diseases (AILDs) in India are rarely reported in comparison to the West...
  29. ncbi request reprint Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis
    Deepak N Amarapurkar
    Gastroenterology Department, Bombay Hospital and Medical Research Center, Mumbai
    Trop Gastroenterol 25:125-9. 2004
    ..Also, all patients with metabolic syndrome should undergo liver function tests and, in the presence of abnormal transaminases, a liver biopsy to define NASH...
  30. ncbi request reprint Consensus on extra-hepatic portal vein obstruction
    Shiv Kumar Sarin
    Department of Gastroenterology, G B Pant Hospital, Affiliated to University of Delhi, New Delhi, India
    Liver Int 26:512-9. 2006
    ..This article summarizes all the consensus statements approved by the APASL on various aspects of EHPVO...
  31. ncbi request reprint Hepatobiliary tuberculosis in western India
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, India
    Indian J Pathol Microbiol 51:175-81. 2008
    ..HBTB forms an important subgroup in TB cases. It requires a combination of imaging, histological and microbiological procedures to define the diagnosis. HBTB responds well to treatment...
  32. ncbi request reprint Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Center, Mumbai
    Trop Gastroenterol 25:130-4. 2004
    ..In patients with diabetes and hepatomegaly in the absence of other obvious liver diseases, even normal ALT may not rule out advanced liver disease, and liver biopsy may be necessary to identify the severity of liver disease...
  33. ncbi request reprint Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia
    Deepak N Amarapurkar
    Bombay Hospital and Medical Research Centre, Mumbai
    J Indian Med Assoc 102:735-7, 760. 2004
    ..7%) (p < 0.05) and poor in 0 (0%) versus 6 (20%) patients respectively. It may be concluded that ganaton (itopride hydrochloride) is superior in efficacy and safety over mosapride citrate in the management of functional dyspepsia...
  34. ncbi request reprint Biliary ascariasis
    Deepak Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, Mumbai, India
    J Hepatol 40:558. 2004
  35. ncbi request reprint Primary biliary cirrhosis and autoimmune hepatitis switch over: report of 2 cases
    Nikhil Patel
    BYL Nair Charitable Hospital, Mumbai, India
    Trop Gastroenterol 26:136-8. 2005
    ..We report 2 cases of primary biliary cirrhosis (PBC) who with time, crossed over to autoimmune hepatitis (AIH). Recognition of such switch over from PBC to AIH is important for appropriate change in management of the patients...
  36. pmc Primary gastric tuberculosis--report of 5 cases
    Deepak N Amarapurkar
    Department of Gastroenterology, Bombay Hospital and Medical Research Centre, India
    BMC Gastroenterol 3:6. 2003
    ..Gastric tuberculosis is rare, and usually associated with pulmonary tuberculosis or an immunodeficient state. Here, we report five cases of gastric tuberculosis in immunocompetent patients without evidence of pulmonary involvement...
  37. ncbi request reprint Helicobacter pylori eradication: efficacy of conventional therapy in India
    Deepak Amarapurkar
    Bombay Hospital and Research Centre, Mumbai, India
    Trop Doct 34:101-2. 2004
  38. ncbi request reprint Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India
    Umapathy Shankarkumar
    HLA Department, Institute of Immunohaematology ICMR, KEM Hospital, Parel, Mumbai 400 012, Maharashtra, India
    J Gastroenterol Hepatol 20:193-7. 2005
    ..The immunogenetic basis of autoimmune diseases has become more and more evident. We have analyzed the human leukocyte antigen (HLA) associations with type-1 autoimmune hepatitis (AIH) among patients from western India...
  39. ncbi request reprint Angiogenesis in chronic liver disease
    Anjali D Amarapurkar
    Department of Pathology, BYL Nair Charitable Hospital and TN Medical College, India
    Ann Hepatol 6:170-3. 2007
    ..Interfering with angiogenesis may be a potential target to avoid progression of liver disease. Hence we planned to evaluate the CD34 and vascular endothelial growth factor (VEGF), the markers for angiogenesis in chronic liver disease...